Based on the comprehensive analysis of sequencing data and in vitro experiments, we determined that DCP2 m6A methylation levels in SCLC were regulated by METTL3, and highly m6A-modified DCP2 mRNA was degraded, resulting in decreased DCP2 protein expression. The gene discussed is METTL3; the disease is small cell lung carcinoma.